PROASSURANCE CORP
Business
PROASSURANCE CORP is a holding company that underwrites specialty property and casualty and workers' compensation insurance through its insurance subsidiaries. It offers medical professional liability, medical technology and life sciences liability, workers' compensation coverages, alternative risk and captive solutions, reinsurance participation and related claims management and risk management services. The company reports results through four operating segments: Specialty P&C, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance and Corporate. Its insurance exposures and distribution are primarily U.S.-focused, marketed through independent agents and brokers, internal business development teams and strategic partnerships.
Summary from filing dated 2025-02-24
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net premiums earned | 934 | 968 | 977 | 1,030 | 972 | |
| Net investment income | 156 | 145 | 128 | 96 | 71 | |
| Equity in earnings (loss) of unconsolidated subsidiaries | 16 | 22 | 7 | 5 | 49 | |
| Impairment losses | −2 | −3 | −3 | −2 | 0 | |
| Portion of impairment losses recognized in other comprehensive income (loss) before taxes | 358,000 | 102,000 | 0 | 14,000 | 0 | |
| Net impairment losses recognized in earnings | −2 | −3 | −3 | −2 | 0 | |
| Other net investment gains (losses) | −4 | 5 | 17 | −31 | 24 | |
| Total net investment gains (losses) | −5 | 2 | 14 | −33 | 24 | |
| Other income (expense) | −3 | 14 | 11 | 9 | 9 | |
| Total revenues | 1,098 | 1,150 | 1,137 | 1,107 | 1,124 | |
| Net losses and loss adjustment expenses | 665 | 739 | 800 | 777 | 752 | |
| Operating expense | 199 | 184 | 166 | 174 | 158 | |
| DPAC amortization | 131 | 135 | 135 | 133 | 111 | |
| SPC U.S. federal income tax expense (benefit) | 2 | 2 | 2 | 2 | 2 | |
| SPC dividend expense (income) | 7 | 4 | 6 | 7 | 10 | |
| Interest expense | 21 | 22 | 23 | 20 | — | |
| Goodwill impairment | 0 | 0 | 44 | 0 | 0 | |
| Total expenses | 1,026 | 1,087 | 1,176 | 1,113 | 1,052 | |
| Income (loss) before income taxes | 72 | 63 | −39 | −6 | 147 | |
| Current expense (benefit) | 4 | −2 | 1 | 807,000 | 1 | |
| Deferred expense (benefit) | 17 | 13 | −2 | −7 | 1 | |
| Total income tax expense (benefit) | 21 | 10 | −545,000 | −6 | 2 | |
| Other comprehensive income (loss), after tax, net of reclassification adjustments | 91 | 32 | 94 | −315 | −59 | |
| Comprehensive income (loss) | 142 | 85 | 56 | −315 | 85 | |
| Basic (in dollars per share) | 0.99 | 1.03 | −0.73 | −0.01 | 2.67 | |
| Diluted (in dollars per share) | 0.99 | 1.03 | −0.73 | −0.01 | 2.67 | |
| Basic (in shares) | 51 | 51 | 53 | 54 | 54 | |
| Diluted (in shares) | 52 | 51 | 53 | 54 | 54 | |
| Cash dividends declared per common share (in dollars per share) | 0 | 0 | 0.05 | 0.2 | 0.2 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Fixed maturities, available-for-sale, at fair value (amortized cost, $3,793,777 and $3,803,835, respectively; allowance for expected credit losses, $4,306 and $3,399, respectively) | 3,686 | 3,582 | 3,494 | 3,472 | 3,834 | |
| Fixed maturities, trading, at fair value (cost, $14,202 and $52,493, respectively) | 14 | 53 | 48 | 43 | 44 | |
| Equity investments, at fair value (cost, $121,766 and $145,411, respectively) | 107 | 130 | 151 | 144 | 215 | |
| Short-term investments | 286 | 255 | 236 | 245 | 217 | |
| Business owned life insurance | 83 | 80 | 78 | 82 | 82 | |
| Investment in unconsolidated subsidiaries | 245 | 260 | 277 | 305 | 336 | |
| Other investments (at fair value, $1,215 and $2,077, respectively, otherwise at cost or amortized cost) | 8 | 7 | 66 | 96 | 102 | |
| Total Investments | 4,429 | 4,367 | 4,350 | 4,388 | 4,828 | |
| Cash and cash equivalents | 36 | 55 | 66 | 30 | 144 | |
| Premiums receivable, net (allowance for expected credit losses, $7,829 and $8,141, respectively) | 228 | 229 | 236 | 246 | 241 | |
| Receivable from reinsurers on paid losses and loss adjustment expenses | 20 | 18 | 21 | 15 | 15 | |
| Receivable from reinsurers on unpaid losses and loss adjustment expenses | 335 | 409 | 446 | 432 | 452 | |
| Prepaid reinsurance premiums | 33 | 31 | 31 | 29 | 25 | |
| Deferred policy acquisition costs | 57 | 59 | 60 | 58 | 59 | |
| Deferred tax asset, net | 122 | 164 | 186 | 210 | 118 | |
| Real estate, net | 13 | 30 | 30 | 30 | 30 | |
| Operating lease ROU assets | 14 | 17 | 16 | 19 | 20 | |
| Intangible assets, net | 49 | 54 | 60 | 67 | 73 | |
| Goodwill | 6 | 6 | 6 | 50 | 50 | |
| Other assets | 106 | 136 | 124 | 127 | 138 | |
| Total Assets | 5,447 | 5,574 | 5,632 | 5,700 | 6,191 | |
| Reserve for losses and loss adjustment expenses | 3,018 | 3,258 | 3,401 | 3,471 | 3,580 | |
| Unearned premiums | 404 | 419 | 434 | 423 | 434 | |
| Reinsurance premiums payable | 14 | 27 | 24 | 29 | 23 | |
| Total Policy Liabilities and Accruals | 3,437 | 3,704 | 3,859 | 3,923 | 4,037 | |
| Operating lease liabilities | 15 | 17 | 17 | 20 | 21 | |
| Other liabilities | 226 | 227 | 217 | 226 | 281 | |
| Debt less unamortized debt issuance costs | 420 | 425 | 427 | 427 | 425 | |
| Total Liabilities | 4,098 | 4,373 | 4,520 | 4,596 | 4,763 | |
| Common shares (par value $0.01 per share, 100,000,000 shares authorized, 64,020,611 and 63,763,789 shares issued, respectively) | 640,000 | 638,000 | 636,000 | 634,000 | 633,000 | |
| Additional paid-in capital | 414 | 408 | 404 | 398 | 393 | |
| Accumulated other comprehensive income (loss) (net of deferred tax expense (benefit) of ($21,905) and ($46,681), respectively) | −81 | −172 | −204 | −299 | 16 | |
| Retained earnings | 1,486 | 1,435 | 1,382 | 1,423 | 1,434 | |
| Treasury shares, at cost (12,606,968 shares as of each respective period end) | −470 | −470 | −470 | −419 | −416 | |
| Total Shareholders' Equity | 1,349 | 1,202 | 1,112 | 1,104 | 1,428 | |
| Total Liabilities and Shareholders' Equity | 5,447 | 5,574 | 5,632 | 5,700 | 6,191 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization, net of accretion | 14 | 18 | 26 | 38 | 37 | |
| (Increase) decrease in cash surrender value of BOLI | −3 | −2 | 4 | 21,000 | −1 | |
| Gain on sale of capital assets | −2 | 0 | 0 | — | — | |
| Net investment (gains) losses | 5 | −2 | −14 | — | — | |
| Share-based compensation | 8 | 6 | 5 | 5 | 4 | |
| Policy acquisition costs, net of amortization (net deferral) | 2 | 1 | −2 | 792,000 | −12 | |
| Distributed earnings from unconsolidated subsidiaries | 23 | 21 | 15 | 30 | 35 | |
| Other, net | 2 | −320,000 | 947,000 | −571,000 | −401,000 | |
| Premiums receivable | 605,000 | 7 | 11 | −5 | 71 | |
| Reinsurance related assets and liabilities | 36 | 43 | −26 | 20 | 17 | |
| Other assets | 14 | −9 | −5 | 12 | 13 | |
| Reserve for losses and loss adjustment expenses | −166 | −144 | −70 | −109 | −20 | |
| Unearned premiums | −15 | −15 | 11 | −11 | −106 | |
| Other liabilities | 4 | 22 | −2 | −32 | 38 | |
| Net cash provided by (used in) operating activities | −26 | −11 | −50 | −30 | 74 | |
| Fixed maturities, available-for-sale | −893 | −770 | −419 | −608 | −1,438 | |
| Equity investments | −4 | −2 | −2 | −35 | −157 | |
| Other investments | −3 | −10 | −41 | −39 | −74 | |
| Investment in unconsolidated subsidiaries | −28 | −26 | −37 | −39 | −50 | |
| Fixed maturities, available-for-sale | 903 | 708 | 494 | 543 | 1,077 | |
| Equity investments | 27 | 24 | 4 | 79 | 441 | |
| Other investments | 934,000 | 69 | 77 | 35 | 59 | |
| Net sales or (purchases) of fixed maturities, trading | 2 | −4 | −5 | −499,000 | 4 | |
| Return of invested capital from unconsolidated subsidiaries | 35 | 44 | 57 | 44 | 65 | |
| Net sales or maturities (purchases) of short-term investments | −29 | −14 | 13 | −28 | 182 | |
| Unsettled security transactions, net change | 1 | 2 | 2 | −6 | 30 | |
| Purchases of capital assets | −4 | −9 | −5 | −4 | −4 | |
| Proceeds from sale of capital assets | 19 | 0 | 0 | — | — | |
| Net cash impact of deconsolidation of closed years of account from Lloyd's Syndicates operations | −11 | 0 | 0 | — | — | |
| Other | 966,000 | 0 | 3 | −3 | 0 | |
| Net cash provided by (used in) investing activities | 19 | 11 | 141 | −62 | −86 | |
| Borrowings (repayments) under Revolving Credit Agreement | −6 | −5 | 250 | 0 | — | |
| Repayments of Senior Notes | 0 | 0 | −250 | 0 | 0 | |
| Repurchase of common stock | 0 | 8,000 | −50 | −3 | — | |
| Dividends to shareholders | 0 | 0 | −5 | −11 | −11 | |
| Capital contribution received from (return of capital to) external segregated portfolio cell participants | −3 | −5 | 4 | −9 | −10 | |
| Other | −3 | −1 | −3 | 1 | −288,000 | |
| Net cash provided by (used in) financing activities | −12 | −11 | −55 | −22 | −61 | |
| Increase (decrease) in cash and cash equivalents | −18 | −11 | 36 | −114 | −72 | |
| Cash paid during the year for interest | 19 | 23 | 22 | 20 | 15 | |
| Operating lease liabilities arising from obtaining ROU assets | 0 | 2 | 0 | 3 | 6 | |
| Increase (decrease) in fair value of contingent consideration issued in NORCAL acquisition | 0 | −7 | −9 | −9 | 0 |